Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
Phase 3
Terminated
- Conditions
- HIV InfectionsPeripheral Nervous System DiseasesPain
- Registration Number
- NCT00085761
- Lead Sponsor
- NeurogesX
- Brief Summary
The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is safe, tolerable and effective in treating painful HIV-associated neuropathy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
NeurogesX Investigational Site
🇺🇸Annandale, Virginia, United States
NeurogesX Investigational Site🇺🇸Annandale, Virginia, United States